These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 10219717

  • 1. Rotavirus vaccines: development and use for the prevention of diarrhoeal disease.
    Vesikari T.
    Ann Med; 1999 Feb; 31(1):79-85. PubMed ID: 10219717
    [Abstract] [Full Text] [Related]

  • 2. Rotavirus vaccines and vaccination in Latin America.
    Linhares AC, Bresee JS.
    Rev Panam Salud Publica; 2000 Nov; 8(5):305-31. PubMed ID: 11190969
    [Abstract] [Full Text] [Related]

  • 3. Rotavirus vaccines against diarrhoeal disease.
    Vesikari T.
    Lancet; 1997 Nov 22; 350(9090):1538-41. PubMed ID: 9388411
    [Abstract] [Full Text] [Related]

  • 4. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ, Flores J, Hoshino Y, Midthun K, Gorziglia M, Green KY, Chanock RM, Potash L, Sears SD, Clements ML.
    Rev Infect Dis; 1989 Nov 22; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [Abstract] [Full Text] [Related]

  • 5. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
    Joensuu J, Koskenniemi E, Pang XL, Vesikari T.
    Lancet; 1997 Oct 25; 350(9086):1205-9. PubMed ID: 9652561
    [Abstract] [Full Text] [Related]

  • 6. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, Kohberger R, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.
    J Infect Dis; 2006 Aug 01; 194(3):370-6. PubMed ID: 16826486
    [Abstract] [Full Text] [Related]

  • 7. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine.
    Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I.
    Arch Virol Suppl; 1996 Aug 01; 12():163-75. PubMed ID: 9015113
    [Abstract] [Full Text] [Related]

  • 8. Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: analysis by severity of diarrhea.
    Linhares AC, Lanata CF, Hausdorff WP, Gabbay YB, Black RE.
    Pediatr Infect Dis J; 1999 Nov 01; 18(11):1001-6. PubMed ID: 10571438
    [Abstract] [Full Text] [Related]

  • 9. Review of rotavirus vaccine trials in Finland.
    Vesikari T, Joensuu J.
    J Infect Dis; 1996 Sep 01; 174 Suppl 1():S81-7. PubMed ID: 8752295
    [Abstract] [Full Text] [Related]

  • 10. Rotaviruses detected by reverse transcription polymerase chain reaction in acute gastroenteritis during a trial of rhesus-human reassortant rotavirus tetravalent vaccine: implications for vaccine efficacy analysis.
    Pang XL, Joensuu J, Hoshino Y, Kapikian AZ, Vesikari T.
    J Clin Virol; 1999 Jun 01; 13(1-2):9-16. PubMed ID: 10405887
    [Abstract] [Full Text] [Related]

  • 11. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group.
    Ward RL, Bernstein DI.
    Vaccine; 1995 Sep 01; 13(13):1226-32. PubMed ID: 8578808
    [Abstract] [Full Text] [Related]

  • 12. Rotavirus.
    Parashar UD, Bresee JS, Gentsch JR, Glass RI.
    Emerg Infect Dis; 1998 Sep 01; 4(4):561-70. PubMed ID: 9866732
    [Abstract] [Full Text] [Related]

  • 13. Divergence of VP7 genes of G1 rotaviruses isolated from infants vaccinated with reassortant rhesus rotaviruses.
    Jin Q, Ward RL, Knowlton DR, Gabbay YB, Linhares AC, Rappaport R, Woods PA, Glass RI, Gentsch JR.
    Arch Virol; 1996 Sep 01; 141(11):2057-76. PubMed ID: 8973523
    [Abstract] [Full Text] [Related]

  • 14. Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial.
    Pang XL, Joensuu J, Vesikari T.
    Pediatr Infect Dis J; 1999 May 01; 18(5):420-6. PubMed ID: 10353514
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines--report of the National Multicenter Trial. United States Rotavirus Vaccine Efficacy Group.
    Rennels MB, Glass RI, Dennehy PH, Bernstein DI, Pichichero ME, Zito ET, Mack ME, Davidson BL, Kapikian AZ.
    Pediatrics; 1996 Jan 01; 97(1):7-13. PubMed ID: 8545227
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical trials of live oral rotavirus vaccines: the Finnish experience.
    Vesikari T.
    Vaccine; 1993 Jan 01; 11(2):255-61. PubMed ID: 8382419
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical and immunological studies of rotavirus vaccines.
    Vesikari T.
    Southeast Asian J Trop Med Public Health; 1988 Sep 01; 19(3):437-47. PubMed ID: 2851185
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA.
    JAMA; 1995 Apr 19; 273(15):1191-6. PubMed ID: 7707626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.